Week Eleven - Psychotic Disorders Flashcards
What do people with psychotic disorders struggle to do? (6)
think clearly communicate properly make good judgements behave appropriately respond emotionally understand reality
Schizophrenia is characterised by?
Major disturbances in thought, emotion and behaviour
- disordered thinking
- lack of emotional expression
- disturbances in movement/behaviour (untidy appearances)
DSM5 diagnostic criteria for schizophrenia?
Two or more symptoms and one symptom should be either 1, 2 or 3 for at least 6 months:
- delusions
- hallucinations
- disorganised speech
- disorganised motor behaviour
- negative symptoms
Positive symptoms of schizophrenia? (2)
Delusions: Firmly held beliefs that are contrary to reality (persecuratory most common)
Hallucinations: Sensory experiences in the absence of sensory stimulation (auditory most common)
Negative symptoms of schizophrenia?
Experience domain
Expression domain
- avolition: lack of interest
- asociality: inability to form close relations
- anhedonia: inability to experience pleasure
blunted: no affect in face/voice
alogia: reduction in speech/intelligence
Other symptoms of schizophrenia?
Disorganised symptoms
- speech
- behaviour
Movement symptoms
- catatonia
- immobility
What are positive symptoms of schizophrenia caused by?
Excess of dopamine in the mesolimbic pathway
- decreasing dopamine in this pathway via an agonist should be effective
What are negative/cognitive symptoms of schizophrenia caused by?
Caused by a shortage of dopamine in the mesocortical pathway
- increasing dopamine in this pathway should be effective
Problems with treating schizophrenia with D2 agonists in the mesolimbic pathway?
Reduces signalling in the mesocortical pathways meaning negative/cognitive symptoms may become worse (at the least they won’t be addressed)
Explain the role of an atypical D2 partial agonist?
Works to reduce dopamine in the mesolimbic, treating pos symptoms - will also act to enhance dopamine signalling, meaning the neg/cog symptoms could be improved as well
- Aripiprazole
The glutamate hypothesis
The predominant ‘go’ NT in the brain is glutamate.
Evidence to suggest implications of glutamate NMDA receptors in Schizophrenia
- post mortem studies
- NMDA receptor agonists can cause psychotic symptoms
Prominent brain area change in schizophrenic patients?
Ventricular enlargement
Results in:
- poor cognition
- poor response to treatment
The pathophysiology of treatment- resistant schizophrenia? (TRS)
Differences between patients with TRS and other schizophrenia (wide spread grey matter)
TRS patients also show reduced connectivity in certain key brain regions
TRS have reduced density of dopaminergic synapses
Neurodevelopment of schizophrenia?
Reduced elaboration of inhibitory pathways and excessive pruning of excitatory pathways leading to altered excitatory-inhibitory balance in the prefrontal cortex
Patients with schizophrenia show what?
Abnormal synaptic communication between neurons in the brain. These occur in several NT systems where disruption in one causes compensatory mechanisms by others
GABA and schizophrenia?
Reduced synthesis and reuptake of GABA has been demonstrated in the prefrontal cortex of patients with schizophrenia